期刊文献+

从抗TNF抗体的CDR肽库中获得拮抗TNF的短肽

Isolation and Characterization of Anti-TNF Peptides from Phage-displayed CDR-based Peptide Libraries
下载PDF
导出
摘要 为设计来自抗体的短肽 ,以抗肿瘤坏死因子 (TNF)嵌合抗体 (cA2 )CDRs为模板 ,在其两侧各加 3个随机氨基酸残基 ( X3 CDR X3 ) ,构建了 6个以CDR为基础的肽库 .经过 3轮亲和选择 ,挑取单克隆 ,进一步经ELISA检测TNF阳性噬菌体克隆 ,分离得到 7个ELISA阳性较好的噬菌体肽克隆 ,分别命名为CDR2L1、CDR2L2、CDR2L3、CDR1L1、CDR2H1、CDR3H1、CDR3H 2 .应用MTT方法 ,检测 7个克隆对TNF生物学活性的拮抗作用 .结果显示 :来自CDR2L ,CDR3H肽库中的CDR2L2、CDR2L3,CDR3H2噬菌体肽具有明显的拮抗TNF诱导L92 9细胞的细胞毒作用 ,其中以CDR2L2噬菌体肽的拮抗活性最强 .而来源于CDR1L ,CDR2H肽库的CDR1L1和CDR2H1噬菌体肽和来自CDR2L ,CDR3H肽库中的CDR2L1和CDR3H1噬菌体肽没有明显的拮抗TNF作用 .研究结果初步表明 :从cA2抗体CDR肽库中筛选得到的噬菌体CDR模拟肽具有亲本抗体相似的结合活性和生物学效应 ,从而为开发已知抗体 (特别是治疗用抗体 ) As complementarity determining regions (CDRs) of antibody could mimic both specific binding to antigen and biological properties, peptide analogues of CDRs can be developed. Corresponding to the deduced CDRs amino acid sequences of cA2, six CDRs based peptide libraries were constructed using phage display technique. cA2 is a chimeric (human mouse) monoclonal antibody against human tumor necrosis factor (TNF) that consists of the variable region of murine anti TNF mAb coupled to the constant region of human IgG1κ. CDR based peptide sequences included amino acid sequences from the CDRs of the Ab and the three random residues flanking CDRs (X3 CDR X3). Phage clones were selected on rh TNFα coated microplate. Clones of phage peptide were obtained and further tested by ELISA. Seven CDR derived peptides were isolated (termed CDR2L1,CDR2L 2,CDR2L 3, CDR1L1, CDR2H1, CDR3H1,CDR3H 2) and showed TNF binding capacity. The activity of inhibiting human recombinant TNF alpha (rhTNF α) was detected on L929 cell using MTT method. The data show that CDR2L2 and CDR3H2 phage peptides can inhibit 38% and 20 7% of TNF alpha activity, respectively when TNF alpha gives 57% cell toxicity on L929 Moreover, CDR2L2 phage peptide of all peptides was most effective in inhibiting TNF induced cytotoxicity on L929 cells. The results indicate that the information obtained from a novel exploration of anti TNF peptide antagonists from CDRs of antibody variable sequences may become a potential identification method in pharmacology. The method could be of interest for the rational identification of biologically active peptides derived from CDRs of therapeutic antibody.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2003年第5期547-551,共5页 Chinese Journal of Biochemistry and Molecular Biology
关键词 肿瘤坏死因子 多肽拮抗剂 噬茵体呈现 互补决定区 tumor necrosis factor, peptide antagonist, phage display, complementarity determining regions
  • 相关文献

参考文献11

  • 1Monnet C, Laurie D, Laroehe-Traineau J, Biard-Piechaczyk M, Briant L , Bes C, Pugniere M, Mani J C, Pau B, Cerutti M, Devauchelle G,Devaux C, Granier C, Chardes T. Synthetic peptides derived from the variable regions of an anti-CD4 monocloal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells. J Biol Chem,1999, 274:3789 - 3796. 被引量:1
  • 2Beutler B. TNF, immunity and inflammatory disease : lessons of the past decade. J Investig Med, 1995, 43:227 - 235. 被引量:1
  • 3Elliott M J, Mainl R N, Feldmann M, Long-Fox A, Charles P,Katsikis P, Brennan F M, Walker J, Bijl H, Ghrayeb J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum, 1993, 36:1681 - 1690. 被引量:1
  • 4Moreland LW, Baumgartner SW, Schitt MH, Tindall EA, Fleisehmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohhr K,Widmer MB, Blosch CM. Treatment of rhenmatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med, 1997, 337:141-147. 被引量:1
  • 5Chirinos-Rojas C L, Steward M W, Partidos C D. A peptidomimetic antagonist of TNF-aipha-mediated cytotoxicity identified from a phagedisplayed random peptide library. J Immunol, 1998, 161:5621-5626. 被引量:1
  • 6Doring E, Stigler R, Grutz G, yon Baehr R, Schneider-Mergener J. Identification and characterization of a TNF alpha antagonist derived from a monoclonal antibody. Mol Immunol. 1994, 31:1059-1067. 被引量:1
  • 7Takasaki W, Kajino Y, Kajino K, Murali R, Greene M I. Structurebased design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor. Nat Biotechnol. 1997, 15:1266 - 1270. 被引量:1
  • 8Dougall W C, Pemrson N C, Greene M I. Antibody-structure-based design of pharmacological agents. Trends Biotechnol , 1994, 12:372-379. 被引量:1
  • 9Knight D M, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore M A, Vilcek J, Daddona P. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol. 1993, 30:1443 - 1453. 被引量:1
  • 10Scott J K, Smith G P. Searching for pepfide liganch with an epitope library. Science, 1990, 249:386-390. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部